Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 373

1.

Distinct Roles of Opioid and Dopamine Systems in Lateral Hypothalamic Intracranial Self-Stimulation.

Ide S, Takahashi T, Takamatsu Y, Uhl GR, Niki H, Sora I, Ikeda K.

Int J Neuropsychopharmacol. 2017 May 1;20(5):403-409. doi: 10.1093/ijnp/pyw113.

2.

Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice.

Drgonova J, Walther D, Hartstein GL, Bukhari MO, Baumann MH, Katz J, Hall FS, Arnold ER, Flax S, Riley A, Rivero-Martin O, Lesch KP, Troncoso J, Ranscht B, Uhl GR.

Mol Med. 2016 Aug 18;22. doi: 10.2119/molmed.2015.00170. [Epub ahead of print]

3.

Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.

Earley CJ, Uhl GR, Clemens S, Ferré S.

Sleep Med. 2017 Mar;31:71-77. doi: 10.1016/j.sleep.2016.06.003. Epub 2016 Jun 27. Review.

PMID:
27539027
4.

Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.

Kitanaka J, Kitanaka N, Hall FS, Uhl GR, Takemura M.

Drug Target Insights. 2016 Mar 2;10:1-7. doi: 10.4137/DTI.S38342. eCollection 2016. Review.

5.

Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice.

Kitanaka N, Kitanaka J, Hall FS, Kayama M, Sugimori H, Uhl GR, Takemura M.

J Exp Neurosci. 2015 Sep 10;9(Suppl 1):1-10. doi: 10.4137/JEN.S27733. eCollection 2015.

6.

Mouse model for PTPRD associations with WED/RLS and addiction: reduced expression alters locomotion, sleep behaviors and cocaine-conditioned place preference.

Drgonova J, Walther D, Wang KJ, Hartstein GL, Lochte B, Troncoso J, Uetani N, Iwakura Y, Uhl GR.

Mol Med. 2015 Jul 14. doi: 10.2119/molmed.2015.00017. [Epub ahead of print]

7.

Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.

Drgonova J, Walther D, Singhal S, Johnson K, Kessler B, Troncoso J, Uhl GR.

PLoS One. 2015 Jul 14;10(7):e0120908. doi: 10.1371/journal.pone.0120908. eCollection 2015.

8.

Human cell adhesion molecules: annotated functional subtypes and overrepresentation of addiction-associated genes.

Zhong X, Drgonova J, Li CY, Uhl GR.

Ann N Y Acad Sci. 2015 Sep;1349:83-95. doi: 10.1111/nyas.12776. Epub 2015 May 18. Review.

9.

Memory impairment and reduced exploratory behavior in mice after administration of systemic morphine.

Kitanaka J, Kitanaka N, Hall FS, Fujii M, Goto A, Kanda Y, Koizumi A, Kuroiwa H, Mibayashi S, Muranishi Y, Otaki S, Sumikawa M, Tanaka K, Nishiyama N, Uhl GR, Takemura M.

J Exp Neurosci. 2015 May 11;9:27-35. doi: 10.4137/JEN.S25057. eCollection 2015.

10.

Region-specific dendritic spine loss of pyramidal neurons in dopamine transporter knockout mice.

Kasahara Y, Arime Y, Hall FS, Uhl GR, Sora I.

Curr Mol Med. 2015;15(3):237-44.

PMID:
25817859
11.

Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.

Takamatsu Y, Hagino Y, Sato A, Takahashi T, Nagasawa SY, Kubo Y, Mizuguchi M, Uhl GR, Sora I, Ikeda K.

Curr Mol Med. 2015;15(3):245-52.

12.

Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.

Piao YS, Hall FS, Moriya Y, Ito M, Ohara A, Kikura-Hanajiri R, Goda Y, Lesch KP, Murphy DL, Uhl GR, Sora I.

Behav Pharmacol. 2015 Jun;26(4):345-52. doi: 10.1097/FBP.0000000000000135.

PMID:
25794333
13.

Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation.

Lee CT, Bendriem RM, Kindberg AA, Worden LT, Williams MP, Drgon T, Mallon BS, Harvey BK, Richie CT, Hamilton RS, Chen J, Errico SL, Tsai SY, Uhl GR, Freed WJ.

Cell Rep. 2015 Feb 3;10(4):616-32. doi: 10.1016/j.celrep.2014.12.050. Epub 2015 Jan 29.

14.

Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.

Hall FS, Sora I, Hen R, Uhl GR.

PLoS One. 2014 Dec 16;9(12):e115009. doi: 10.1371/journal.pone.0115009. eCollection 2014.

15.

Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.

Igari M, Shen HW, Hagino Y, Fukushima S, Kasahara Y, Lesch KP, Murphy DL, Hall FS, Uhl GR, Ikeda K, Yaegashi N, Sora I.

Behav Pharmacol. 2015 Feb;26(1-2):167-79. doi: 10.1097/FBP.0000000000000120.

PMID:
25485646
16.

Sex differences in the effects of adolescent social deprivation on alcohol consumption in μ-opioid receptor knockout mice.

Moriya Y, Kasahara Y, Hall FS, Sakakibara Y, Uhl GR, Tomita H, Sora I.

Psychopharmacology (Berl). 2015 Apr;232(8):1471-82. doi: 10.1007/s00213-014-3784-y. Epub 2014 Nov 4.

PMID:
25363463
17.

Preface for Addiction Reviews.

Uhl GR.

Ann N Y Acad Sci. 2014 Oct;1327:v. doi: 10.1111/nyas.12563. No abstract available.

PMID:
25336391
18.

Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry.

Sasaki K, Sumiyoshi A, Nonaka H, Kasahara Y, Ikeda K, Hall FS, Uhl GR, Watanabe M, Kawashima R, Sora I.

Br J Pharmacol. 2015 Jan;172(2):654-67. doi: 10.1111/bph.12807. Epub 2014 Sep 5.

19.

Developmental alterations in anxiety and cognitive behavior in serotonin transporter mutant mice.

Sakakibara Y, Kasahara Y, Hall FS, Lesch KP, Murphy DL, Uhl GR, Sora I.

Psychopharmacology (Berl). 2014 Oct;231(21):4119-33. doi: 10.1007/s00213-014-3554-x. Epub 2014 Apr 13.

PMID:
24728652
20.

Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.

Kitanaka N, Kitanaka J, Hall FS, Uhl GR, Watabe K, Kubo H, Takahashi H, Tanaka K, Nishiyama N, Takemura M.

Behav Pharmacol. 2014 Apr;25(2):158-65. doi: 10.1097/FBP.0000000000000030.

PMID:
24557322

Supplemental Content

Support Center